FI105096B - Menetelmä terapeuttisesti käyttökelpoisten 3-(pyridinyyliamino)indolien ja -bentso[b]tiofeenien valmistamiseksi - Google Patents
Menetelmä terapeuttisesti käyttökelpoisten 3-(pyridinyyliamino)indolien ja -bentso[b]tiofeenien valmistamiseksi Download PDFInfo
- Publication number
- FI105096B FI105096B FI921693A FI921693A FI105096B FI 105096 B FI105096 B FI 105096B FI 921693 A FI921693 A FI 921693A FI 921693 A FI921693 A FI 921693A FI 105096 B FI105096 B FI 105096B
- Authority
- FI
- Finland
- Prior art keywords
- formula
- compound
- lower alkyl
- hydrogen
- pyridinylamino
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Public Health (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/688,964 US5177088A (en) | 1991-04-17 | 1991-04-17 | Substituted 3-(pyridinylamino)-indoles |
US68896491 | 1991-04-17 |
Publications (3)
Publication Number | Publication Date |
---|---|
FI921693A0 FI921693A0 (fi) | 1992-04-15 |
FI921693A FI921693A (fi) | 1992-10-18 |
FI105096B true FI105096B (fi) | 2000-06-15 |
Family
ID=24766519
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI921693A FI105096B (fi) | 1991-04-17 | 1992-04-15 | Menetelmä terapeuttisesti käyttökelpoisten 3-(pyridinyyliamino)indolien ja -bentso[b]tiofeenien valmistamiseksi |
Country Status (25)
Country | Link |
---|---|
US (1) | US5177088A (el) |
EP (1) | EP0509402B1 (el) |
JP (1) | JP2617650B2 (el) |
KR (1) | KR100254027B1 (el) |
AT (1) | ATE161840T1 (el) |
AU (1) | AU655253B2 (el) |
BG (1) | BG61034B1 (el) |
CA (1) | CA2066332C (el) |
CS (1) | CS117192A3 (el) |
DE (1) | DE69223837T2 (el) |
DK (1) | DK0509402T3 (el) |
ES (1) | ES2111580T3 (el) |
FI (1) | FI105096B (el) |
GR (1) | GR3026317T3 (el) |
HU (1) | HU215113B (el) |
IE (1) | IE921235A1 (el) |
IL (1) | IL101599A (el) |
MX (1) | MX9201759A (el) |
NO (1) | NO180486C (el) |
NZ (1) | NZ242359A (el) |
PL (1) | PL168905B1 (el) |
RO (1) | RO109847B1 (el) |
RU (1) | RU2060254C1 (el) |
TW (1) | TW200477B (el) |
ZA (1) | ZA922807B (el) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5264442A (en) * | 1990-08-13 | 1993-11-23 | Hoechst-Roussel Pharmaceuticals Incorporated | Carbamoyl-1-(pyridinylalkyl)-1H-indoles, indolines and related analogs |
US5328920A (en) * | 1991-04-17 | 1994-07-12 | Hoechst-Roussel Pharmaceuticals Incorporated | Substituted (pyridinylamino)-indoles |
US5185350A (en) * | 1991-09-23 | 1993-02-09 | Hoechst-Roussel Pharmaceuticals Incorporated | Substituted pyridinylamino-1h-indoles,1h-indazoles,2h-indazoles, benzo (b)thiophenes and 1,2-benzisothiazoles |
US5356910A (en) * | 1993-07-19 | 1994-10-18 | Hoechst-Roussel Pharmaceuticals Inc. | Use of N-(pyridinyl)-1H-indol-1-amines for the treatment of obsessive-compulsive disorder |
US5668154A (en) * | 1995-06-06 | 1997-09-16 | Hoechst Marion Roussel Inc. | Pyridiniminyl-1,2-benzisoxazoles and -benzisothiazoles |
DE69611783T2 (de) * | 1995-06-06 | 2001-09-20 | Aventis Pharma Inc | Benzisoxazol- und indazol- derivate als antipsychotika |
JP4256937B2 (ja) * | 1996-12-27 | 2009-04-22 | アベンティス・ファーマスーティカルズ・インコーポレイテッド | N−(ピリジニルアミノ)イソインドリン類および関連化合物 |
US7091199B1 (en) | 1999-09-14 | 2006-08-15 | Aventis Pharmaceuticals Inc. | Thienoisoxazole phenoxy unsubstituted ethyl and propyl derivatives useful as d4 antagonists |
US7253165B2 (en) * | 1999-09-14 | 2007-08-07 | Aventis Pharmaceuticals Inc. | Benzisoxazolyl-, pyridoisoxazolyl-and benzthienyl-phenoxy derivatives useful as D4 antagonists |
BR0014000A (pt) * | 1999-09-14 | 2002-05-14 | Aventis Pharma Inc | Derivados de benzisoxazolila-, piridoisoxazolila- e benztienila-fenóxi úteis como antagonistas de d4 |
US7125903B1 (en) | 1999-09-14 | 2006-10-24 | Aventis Pharmaceuticals Inc. | Thienoisoxazolyl-and thienylpyrrazolyl-phenoxy substituted propyl derivatives useful as D4 antagonists |
DE10029371A1 (de) * | 2000-06-20 | 2002-01-03 | Merck Patent Gmbh | Heterocyclische Aminoalkylpyridinderivate als Psychopharmaka |
GB0217920D0 (en) * | 2002-04-23 | 2002-09-11 | Aventis Pharm Prod Inc | Interleukin-4 Gene Expression inhibitors |
EP1756054B1 (en) | 2004-06-01 | 2010-03-31 | F.Hoffmann-La Roche Ag | 3-amino-1-arylpropyl indoles as monoamine reuptake inhibitor |
WO2007062996A1 (en) | 2005-11-30 | 2007-06-07 | F. Hoffmann-La Roche Ag | 3-amino-1-arylpropyl indoles and aza-substituted indoles |
EP2351737A1 (en) * | 2005-11-30 | 2011-08-03 | F. Hoffmann-La Roche AG | 3-Amino-1-arylpropyl indoles and aza-substituted indoles |
ATE442368T1 (de) | 2005-11-30 | 2009-09-15 | Hoffmann La Roche | 3-amino-2-arylpropylazaindole und anwendungen davon |
US20100291533A1 (en) * | 2008-01-04 | 2010-11-18 | Soon Ha Kim | Indole and indazole derivatives having a cell-, tissue- and organ-preserving effect |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0049779B1 (en) * | 1980-09-18 | 1984-10-31 | Asahi Kasei Kogyo Kabushiki Kaisha | 3-aminoindazole derivatives and process for preparation thereof |
IE58370B1 (en) * | 1985-04-10 | 1993-09-08 | Lundbeck & Co As H | Indole derivatives |
US4717658A (en) * | 1985-12-03 | 1988-01-05 | Miles Inc. | Gram negative bacteria screening method with horseshoe crab amebocyte lysate (LAL) |
US4970218A (en) * | 1987-04-24 | 1990-11-13 | Hoechst-Roussel Pharmaceuticals Inc. | N-(pyridinyl)-1H-indol-1-amines |
US4806554A (en) * | 1988-01-11 | 1989-02-21 | Hoechst-Roussel Pharmaceuticals, Inc. | Pyrazol and indazolpyridinamines |
US4954502A (en) * | 1988-06-10 | 1990-09-04 | Bristol-Myers Squibb Company | 1-indolyalkyl-4-(substituted-pyridinyl)piperazines |
ES2076253T3 (es) * | 1989-05-19 | 1995-11-01 | Hoechst Roussel Pharma | N-(ariloxialquil)-heteroarilpiperidinas y -heteroarilpiperazinas, un procedimiento para su preparacion y su uso como medicamentos. |
US4983615A (en) * | 1989-06-28 | 1991-01-08 | Hoechst-Roussel Pharmaceuticals Inc. | Heteroarylamino- and heteroaryloxypyridinamine compounds which are useful in treating skin disorders |
US4954503A (en) * | 1989-09-11 | 1990-09-04 | Hoechst-Roussel Pharmaceuticals, Inc. | 3-(1-substituted-4-piperazinyl)-1H-indazoles |
CA2030051C (en) * | 1989-11-17 | 2001-08-07 | Haruhiko Kikuchi | Indole derivatives |
-
1991
- 1991-04-17 US US07/688,964 patent/US5177088A/en not_active Expired - Lifetime
-
1992
- 1992-04-09 ES ES92106162T patent/ES2111580T3/es not_active Expired - Lifetime
- 1992-04-09 BG BG96202A patent/BG61034B1/bg unknown
- 1992-04-09 DK DK92106162T patent/DK0509402T3/da active
- 1992-04-09 AT AT92106162T patent/ATE161840T1/de not_active IP Right Cessation
- 1992-04-09 EP EP92106162A patent/EP0509402B1/en not_active Expired - Lifetime
- 1992-04-09 DE DE69223837T patent/DE69223837T2/de not_active Expired - Fee Related
- 1992-04-14 RO RO92-200519A patent/RO109847B1/ro unknown
- 1992-04-14 NZ NZ242359A patent/NZ242359A/en unknown
- 1992-04-14 MX MX9201759A patent/MX9201759A/es unknown
- 1992-04-15 FI FI921693A patent/FI105096B/fi active
- 1992-04-15 NO NO921505A patent/NO180486C/no unknown
- 1992-04-15 PL PL92294239A patent/PL168905B1/pl unknown
- 1992-04-15 IL IL10159992A patent/IL101599A/en not_active IP Right Cessation
- 1992-04-16 RU SU925011369A patent/RU2060254C1/ru active
- 1992-04-16 HU HU9201297A patent/HU215113B/hu not_active IP Right Cessation
- 1992-04-16 CS CS921171A patent/CS117192A3/cs unknown
- 1992-04-16 CA CA002066332A patent/CA2066332C/en not_active Expired - Fee Related
- 1992-04-16 ZA ZA922807A patent/ZA922807B/xx unknown
- 1992-04-16 KR KR1019920006338A patent/KR100254027B1/ko not_active IP Right Cessation
- 1992-04-16 JP JP4096304A patent/JP2617650B2/ja not_active Expired - Fee Related
- 1992-04-16 IE IE123592A patent/IE921235A1/en not_active IP Right Cessation
- 1992-04-21 AU AU15121/92A patent/AU655253B2/en not_active Ceased
- 1992-04-24 TW TW081103218A patent/TW200477B/zh active
-
1998
- 1998-03-11 GR GR980400508T patent/GR3026317T3/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI105096B (fi) | Menetelmä terapeuttisesti käyttökelpoisten 3-(pyridinyyliamino)indolien ja -bentso[b]tiofeenien valmistamiseksi | |
Street et al. | Synthesis and serotonergic activity of 5-(oxadiazolyl) tryptamines: potent agonists for 5-HT1D receptors | |
EP1509501B1 (en) | 1-(aminoalkyl)-3-sulfonylindole and -indazole derivatives as 5-hydroxytryptamine-6 ligands | |
WO2002078693A2 (en) | N-(2-arylethyl)benzylamines as antagonists of the 5-ht6 receptor | |
AU2002303094A1 (en) | N-(2-arylethyl)benzylamines as antagonists of the 5-HT6 receptor | |
US5328920A (en) | Substituted (pyridinylamino)-indoles | |
US5856335A (en) | Substituted aminothienopyridines, pharmaceutical composition and use | |
CA2078814C (en) | Substituted pyridinylamino-1h-indoles, 1h-indazoles, 2h-indazoles, benzo[b]thiophenes and 1,2-benzisothiazoles, a process for their preparation and their use as medicaments | |
US5424322A (en) | A personality disorder treatment method and composition | |
US6022880A (en) | Substituted pyridylamino indoles | |
US5229401A (en) | Substituted pyridinylamino benzo[b]thiophene compounds | |
EP1859798B1 (en) | N-(2-arylethyl) benzylamines as antagonists of the 5-ht6 receptor | |
CA2327513A1 (en) | N-aryloxyethyl-indoly-alkylamines for the treatment of depression |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
GB | Transfer or assigment of application |
Owner name: HOECHST MARION ROUSSEL, INC. |
|
PC | Transfer of assignment of patent |
Owner name: AVENTIS PHARMACEUTICALS INC. |